News on this topic
Marlboro maker Altria opts to end non-compete deal with Juul: Marlboro maker Altria Group Inc (MO.N) said it had exercised the option to be released from its ...
reuters.com/business/altria-opts-end-non-compete-agreement-with-juul-2022-09-30/
More news on this subject
Previous
Marlboro maker Altria opts to end non-compete deal with Juul: Marlboro maker Altria Group Inc (MO.N) said it had exercised the option to be released from its ...
reuters.com/business/altria-opts-end-non-compete-agreement-with-juul-2022-09-30/
Fears grow over Comstock Act, Justices Thomas, Alito: Abortion rights supporters are sounding the alarm that conservative Supreme Court justices want to use a ...
thehill.com/policy/healthcare/4560476-fears-grow-over-comstock-act-justices-thomas-alito/
Quick Glance: The Significance of the Supreme Court Mifepristone Case
- On June 24, 2022, the constitutional jurisprudence on abortions was overturned by the Supreme Court.
- A pivotal aspect in the dispute FDA v. Alliance for Hippocratic Medicine revolves around making access to medication abortions more challenging.
- The decision could impact not only abortion access but also have implications for miscarriage treatment.
- There are also repercussions for the entire country, voters' preferences in blue states, and state sovereignty.
PLBY Group, Inc. (PLBY) Q4 2023 Earnings Call Transcript: PLBY Group, Inc. (NASDAQ:NASDAQ:PLBY) Q4 2023 Earnings Conference Call March 27 ...
seekingalpha.com/article/4680878-plby-group-inc-plby-q4-2023-earnings-call-transcript
Exclusive: US lawmaker seeks answers on FDA inspection of Musk's Neuralink: A U.S. lawmaker involved in health policy has asked the Food and Drug Administration ...
reut.rs/3TQQDVp
Quick Glance: Neuralink patient controls 'Mario Kart' with mind
- A video from Neuralink demonstrates the first human patient using his brain-chip implant to play 'Mario Kart.'
- In a gathering with Neuralink employees, the first patient, Noland Arbaugh, was introduced to explain the capabilities of the brain chip.
- Arbaugh, a quadriplegic due to a swimming accident, highlighted how the device enables him to engage in activities like gaming.
- Since the revelation of the first human patient, Arbaugh has showcased tasks achievable with his new brain implant, from gaming late into the night to sharing content on X.
Lululemon Athletica Inc. (LULU) Q4 2023 Earnings Call Transcript: Lululemon Athletica Inc. (NASDAQ:NASDAQ:LULU) Q4 2023 Earnings Call Transcript March 21 ...
seekingalpha.com/article/4679790-lululemon-athletica-inc-lulu-q4-2023-earnings-call-transcript
US FDA approves Merck's therapy for rare lung condition: The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-mercks-blood-pressure-therapy-2024-03-26/
FDA OKs New Treatment to Prevent COVID in High-Risk People: A new antibody treatment has been approved to help prevent COVID-19, and it will be available in a ...
webmd.com/covid/news/20240326/fda-oks-new-treatment-to-prevent-covid-high-risk-people
Quick Glance: FDA Grants Approval for New Treatment to Prevent COVID in High-Risk Individuals
- A newly approved antibody therapy aims to prevent COVID-19 in individuals who are particularly vulnerable.
- Known as Pemgarda, the monoclonal antibody inhibits the virus from binding to human cells and is administered intravenously.
- Close monitoring is required post-antibody treatment due to severe allergic reactions experienced by some individuals.
- Studies indicate that individuals with weakened immune systems continue to face an increased risk of severe COVID outcomes despite multiple COVID vaccinations.
U.S. FDA approves Akebia's anemia drug: The U.S. Food and Drug Administration approved Akebia Therapeutics' drug, vadadustat, to treat anemia caused by chronic ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-akebias-anemia-drug-2024-03-28/
FDA Opens the Door to Clinical Use of LSD: Studies show benefits for people with high anxiety, depression, and PTSD, but there are questions about how these ...
webmd.com/mental-health/news/20240326/fda-opens-the-door-clinical-use-lsd
Sprinklr, Inc. (CXM) Q4 2024 Earnings Call Transcript: Sprinklr, Inc. (NYSE:NYSE:CXM) Q4 2024 Earnings Conference Call March 27, 2024 5:00 PM ETCompany ...
seekingalpha.com/article/4680884-sprinklr-inc-cxm-q4-2024-earnings-call-transcript
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2023 Earnings Call Transcript: Corvus Pharmaceuticals, Inc. (NASDAQ:NASDAQ:CRVS) Q4 2023 Earnings Conference Call March 19 ...
seekingalpha.com/article/4679254-corvus-pharmaceuticals-inc-crvs-q4-2023-earnings-call-transcript
Taysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcript: Taysha Gene Therapies, Inc. (NASDAQ:NASDAQ:TSHA) Q4 2023 Earnings Conference Call March 19 ...
seekingalpha.com/article/4679255-taysha-gene-therapies-inc-tsha-q4-2023-earnings-call-transcript
Oncolytics Biotech, Inc. (ONCY) Q4 2023 Earnings Call Transcript: Oncolytics Biotech, Inc. (NASDAQ:NASDAQ:ONCY) Q4 2023 Earnings Conference Call March 7 ...
seekingalpha.com/article/4677143-oncolytics-biotech-inc-oncy-q4-2023-earnings-call-transcript
SARMs: What’s the Harm?: SARMs alter your hormones to build muscle. They’ve been shown to have similar effects and risks to anabolic steroids and aren’t approved ...
health.clevelandclinic.org/sarms-harmful-side-effects-and-risks
High Tide Inc. (HITI) Q1 2024 Earnings Call Transcript: High Tide Inc. (NASDAQ:NASDAQ:HITI) Q1 2024 Results Conference Call March 18, 2024 11:30 AM ETCompany ...
seekingalpha.com/article/4678958-high-tide-inc-hiti-q1-2024-earnings-call-transcript
Kingstone Companies, Inc. (KINS) Q4 2023 Earnings Call Transcript: Kingstone Companies, Inc. (NASDAQ:NASDAQ:KINS) Q4 2023 Results Earnings Conference Call March ...
seekingalpha.com/article/4680980-kingstone-companies-inc-kins-q4-2023-earnings-call-transcript
OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript: OmniAb, Inc. (NASDAQ:NASDAQ:OABI) Q4 2023 Earnings Conference Call March 20, 2024 4:30 PM ETCompany ...
seekingalpha.com/article/4679499-omniab-inc-oabi-q4-2023-earnings-call-transcript
FDA proposes to ban certain shock devices for the second time: The U.S. Food and Drug Administration said on Monday it has proposed a ban of electrical ...
reuters.com/business/healthcare-pharmaceuticals/fda-proposes-ban-certain-shock-devices-second-time-2024-03-25/
Ketanji Brown Jackson Dunks on Alito During Abortion Hearing: He wanted to know if the FDA was infallible. She wondered the same about judges.
thedailybeast.com/ketanji-brown-jackson-dunks-on-alito-during-abortion-hearing
Paid articlePaid
F.D.A. Authorizes a New Covid Drug to Protect High-Risk People: Pemgarda, available in the coming weeks, is intended for immunocompromised people who are ...
nytimes.com/2024/03/25/well/fda-covid-medicine-immunocompromised.html
Avoid Bitcoin Miner TeraWulf Inc.: TeraWulf generated more cash from issuing stock than from operating revenue and has not been able to generate net income ...
seekingalpha.com/article/4680027-avoid-bitcoin-miner-terawulf-inc
Paid articlePaid
Elon Musk Takes Ketamine to Help Treat Depression: Does It Work?: In a recent interview, Elon Musk revealed he takes ketamine to help boost his mental health and ...
healthline.com/health-news/elon-musk-ketamine-depression-treatment
Mifepristone access is coming before the US Supreme Court. How safe is this abortion pill?
apnews.com/article/mifepristone-abortion-pill-supreme-court-1d2221251197a391c9bca833918e4554
FactSet Research Systems Inc. (FDS) Q2 2024 Earnings Call Transcript: FactSet Research Systems Inc. (NYSE:NYSE:FDS) Q2 2024 Earnings Conference Call March 21 ...
seekingalpha.com/article/4679784-factset-research-systems-inc-fds-q2-2024-earnings-call-transcript
Tick-killing pill shows promising results in human trial: Should it pan out, the pill would be a new weapon against Lyme disease.
wired.com/story/pill-kills-ticks-lyme-disease-babesiosis-anaplasmosis/
Quick Glance: New Tick-Killing Pill: Hope Against Lyme Disease
- Tarsus Pharmaceuticals is developing a pill for humans that paralyzes and kills ticks to protect against Lyme disease.
- The pill has shown promising results in a small trial, killing ticks within 24 hours of drug intake and lasting effects for up to 30 days.
- The development of this pill could not only protect against Lyme disease but also other tick-borne diseases like babesiosis and anaplasmosis.
- While the efficacy of the pill in preventing Lyme disease is yet to be proven, cautious optimism surrounds its potential as a preventive measure for individuals in tick-infested areas.
AlTi Global, Inc. 2023 Q4 - Results - Earnings Call Presentation: The following slide deck was published by AlTi Global, Inc.
seekingalpha.com/article/4678613-alti-global-inc-2023-q4-results-earnings-call-presentation
Paid articlePaid
Gold Resource Corporation (GORO) Q4 2023 Earnings Call Transcript: Gold Resource Corporation (NYSE:NYSE:GORO) Q4 2023 Earnings Conference Call March 14 ...
seekingalpha.com/article/4678301-gold-resource-corporation-goro-q4-2023-earnings-call-transcript
NIKE, Inc. (NKE) Q3 2024 Earnings Call Transcript: NIKE, Inc. (NYSE:NYSE:NKE) Q3 2024 Earnings Conference Call March 21, 2024 5:00 PM ETCompany ParticipantsPaul ...
seekingalpha.com/article/4679800-nike-inc-nke-q3-2024-earnings-call-transcript
Chewy, Inc. (CHWY) Q4 2023 Earnings Call Transcript: Chewy, Inc. (NYSE:NYSE:CHWY) Q4 2023 Earnings Conference Call March 20, 2024 5:00 PM ETCompany ...
seekingalpha.com/article/4679504-chewy-inc-chwy-q4-2023-earnings-call-transcript
The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD), an inherited muscle-wasting disorder ... Show more
US FDA classifies recall of Vyaire Medical's respiratory devices as most serious: The U.S. Food and Drug Administration on Thursday classified the recall of ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-classifies-recall-vyaire-medicals-respiratory-devices-most-serious-2024-03-21/
A Psychedelics Reporter With a Changing Perspective: Can an experimental drug cure opioid addiction? Andrew Jacobs, who writes about psychedelic medicine for The ...
nytimes.com/2024/03/20/insider/psychedelic-ibogaine.html
US FDA approves first drug for fatty liver disease NASH: The U.S. FDA has approved Madrigal Pharmaceuticals' drug for a fatty liver disease known as ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-drug-fatty-liver-disease-nash-2024-03-14/
Quick Glance: First Drug Approval for Fatty Liver Disease NASH by US FDA
- The US FDA has approved Madrigal Pharmaceuticals' drug for the fatty liver disease NASH.
- NASH, now known as metabolic dysfunction-associated steatohepatitis (MASH), affects about 1.5 million Americans.
- The drug will be available in April and is seen as a pivotal moment for patients.
- Other companies are also conducting trials of their drugs for NASH to meet the much-needed treatment.
Micron Technology, Inc. 2024 Q2 - Results - Earnings Call Presentation: The following slide deck was published by Micron Technology, Inc.
seekingalpha.com/article/4679496-micron-technology-inc-2024-q2-results-earnings-call-presentation
Paid articlePaid
Alpine Immune Sciences, Inc. (ALPN) Q4 2023 Earnings Call Transcript: Alpine Immune Sciences, Inc. (NASDAQ:NASDAQ:ALPN) Q4 2023 Results Conference Call March 18 ...
seekingalpha.com/article/4679006-alpine-immune-sciences-inc-alpn-q4-2023-earnings-call-transcript
STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript: STRATA Skin Sciences, Inc. (NASDAQ:NASDAQ:SSKN) Q4 2023 Earnings Conference Call March 27 ...
seekingalpha.com/article/4680880-strata-skin-sciences-inc-sskn-q4-2023-earnings-call-transcript
Experts Warn of Toxins in GM Corn Amid US-Mexico Trade Dispute: "The Mexican government is both wise and on solid ground in refusing to allow its people to ...
commondreams.org/news/genetically-modified-corn
FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice
cnn.com/2024/03/27/health/fda-ivermectin-lawsuit/
Paid articlePaid
Lifesaving gene therapy for kids is world’s priciest drug at $4.25M: It's unclear if government and private insurance plans can cover the costs.
arstechnica.com/science/2024/03/lifesaving-gene-therapy-for-kids-is-worlds-priciest-drug-at-4-25m/
Brady Corporation: Securing Products: Brady generates sales through its identification solutions segment and workplace safety activities ...
seekingalpha.com/article/4678818-brady-corporation-securing-products
Paid articlePaid
FDA's graphic warning labels for cigarettes are constitutional, US appeals court rules
reuters.com/legal/fda-cigarette-warning-labels-satisfy-first-amendment-us-appeals-court-rules-2024-03-21/
Journey Medical Corporation (DERM) Q4 2023 Earning Call Transcript: Journey Medical Corporation (NASDAQ:NASDAQ:DERM) Q4 2023 Earnings Conference Call March 21 ...
seekingalpha.com/article/4679797-journey-medical-corporation-derm-q4-2023-earning-call-transcript
Peraso Inc. (PRSO) Q4 2023 Earnings Call Transcript: Peraso Inc. (NASDAQ:NASDAQ:PRSO) Q4 2023 Earnings Conference Call March 18, 2024 5:00 PM ETCompany ...
seekingalpha.com/article/4679003-peraso-inc-prso-q4-2023-earnings-call-transcript
US FDA grants full approval to AbbVie's ovarian cancer therapy: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for ...
reut.rs/496Piyi
First over-the-counter birth control pill now for sale online: Opill, an over-the-counter birth control pill, goes on sale online today. The pill is expected to ...
npr.org/sections/health-shots/2024/03/04/1235404522/opill-over-counter-birth-control-pill-contraceptive-shop
Seelos Therapeutics' ALS treatment fails mid-stage study: Seelos Therapeutics' experimental ALS drug did not meet the main goal of a mid-stage trial ...
reuters.com/business/healthcare-pharmaceuticals/seelos-says-als-treatment-fails-mid-stage-study-2024-03-19/
Red Cat Holdings, Inc. (RCAT) Q3 2024 Earnings Call Transcript: Red Cat Holdings, Inc. (NASDAQ:NASDAQ:RCAT) Q3 2024 Results Conference Call March 18 ...
seekingalpha.com/article/4679008-red-cat-holdings-inc-rcat-q3-2024-earnings-call-transcript
Trevi Therapeutics, Inc. (TRVI) Q4 2023 Earnings Call Transcript: Trevi Therapeutics, Inc. (NASDAQ:NASDAQ:TRVI) Q4 2023 Earnings Conference Call March 20 ...
seekingalpha.com/article/4679489-trevi-therapeutics-inc-trvi-q4-2023-earnings-call-transcript
Editas Medicine, Inc. (EDIT) Leerink Partners Global Biopharma Conference (Transcript)
seekingalpha.com/article/4677715-editas-medicine-inc-edit-leerink-partners-global-biopharma-conference-transcript
Fuel Tech, Inc. (FTEK) Q4 2023 Earnings Call Transcript: Fuel Tech, Inc. (NASDAQ:NASDAQ:FTEK) Q4 2023 Earnings Conference Call March 12, 2024 10:00 AM ETCompany ...
seekingalpha.com/article/4677709-fuel-tech-inc-ftek-q4-2023-earnings-call-transcript
Wegovy is now covered by Medicare, but not for weight loss | Here & Now: Wegovy will be covered to prevent heart problems in people with obesity and heart ...
wbur.org/hereandnow/2024/03/26/wegovy-medicare-weight-loss
Oil-Dri Corporation of America (ODC) Q2 2024 Earnings Call Transcript: Oil-Dri Corporation of America (NYSE:NYSE:ODC) Q2 2024 Earnings Conference Call March 8 ...
seekingalpha.com/article/4677133-oil-dri-corporation-of-america-odc-q2-2024-earnings-call-transcript
Largo Inc. (LGO) Q4 2023 Earnings Call Transcript: Largo Inc. (NASDAQ:NASDAQ:LGO) Q4 2023 Earnings Conference Call March 22, 2024 1:00 PM ETCompany ...
seekingalpha.com/article/4680033-largo-inc-lgo-q4-2023-earnings-call-transcript
Five Below, Inc. (FIVE) Q4 2023 Earnings Call Transcript: Five Below, Inc. (NASDAQ:NASDAQ:FIVE) Q4 2023 Earnings Conference Call March 20 ...
seekingalpha.com/article/4679505-five-below-inc-five-q4-2023-earnings-call-transcript
Hiltzik: The FDA and a bogus COVID treatment : Three right-wing doctors said the FDA's advice against taking ivermectin for COVID infringed on their rights ...
latimes.com/business/story/2024-03-26/column-the-fda-shoots-itself-in-the-foot-by-settling-a-dumb-lawsuit-over-ivermectin
Singular Genomics Systems, Inc. (OMIC) Q4 2023 Earnings Call Transcript: Singular Genomics Systems, Inc. (NASDAQ:NASDAQ:OMIC) Q4 2023 Earnings Conference Call ...
seekingalpha.com/article/4679000-singular-genomics-systems-inc-omic-q4-2023-earnings-call-transcript
US FDA panel votes in favor of expanded use of Bristol Myers' CAR-T therapy: Advisers to the U.S. Food and Drug Administration on Friday voted in favor of ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-favor-expanded-use-bristol-myers-car-t-therapy-2024-03-15/
US FDA approves BeiGene's esophageal cancer therapy: The U.S. Food and Drug Administration said it has approved BeiGene's drug to treat a type of advanced ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-beigenes-esophageal-cancer-therapy-2024-03-14/
AT&T Inc. (T) Deutsche Bank's 32 Annual Media, Internet & Telecom Conference (Transcript)
seekingalpha.com/article/4677713-t-inc-t-deutsche-banks-32-annual-media-internet-and-telecom-conference-transcript
Elon Musk says ketamine can get you out of a 'negative frame of mind'. What does the research say?
abc.net.au/news/2024-03-23/elon-musk-ketamine-negative-state-of-mind-research-say/103619394
Wegovy to be covered by US Medicare for heart disease patients: Heart patients insured under the U.S. Medicare program would be covered for Novo Nordisk's ...
reuters.com/business/healthcare-pharmaceuticals/wegovy-be-covered-by-us-medicare-heart-disease-patients-2024-03-21/
Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript: Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q4 2023 Earnings Conference Call March 18 ...
seekingalpha.com/article/4678929-biofrontera-inc-bfri-q4-2023-earnings-call-transcript
FDA authorizes drug to boost COVID protection for immunocompromised patients: It will offer added protection to high-risk patients who may have weaker responses ...
axios.com/2024/03/25/covid-antibody-fda
National CineMedia, Inc. (NCMI) Q4 2023 Earnings Call Transcript: National CineMedia, Inc. (NASDAQ:NASDAQ:NCMI) Q4 2023 Earnings Conference Call March 18 ...
seekingalpha.com/article/4679004-national-cinemedia-inc-ncmi-q4-2023-earnings-call-transcript
In Early Study, People on Weight Loss Pill Lost 13% of Their Body Weight: Novo Nordisk is testing a new weight-loss pill, called amycretin, that is said to lead ...
healthline.com/health-news/in-early-study-people-on-weight-loss-pill-lost-13-of-their-body-weight
Companies Can Claim Yogurt Reduces Diabetes Risk, FDA Says: Yogurt manufacturers can now claim that eating yogurt reduces a person’s risk of type 2 diabetes ...
webmd.com/diabetes/news/20240304/companies-can-claim-yogurt-reduces-diabetes-risk-fda-says
Trader Joe's nut recall: Select lots of cashews recalled for potential salmonella risk
usatoday.com/story/money/food/2024/03/18/salmonella-detected-in-cashews-sold-at-trader-joes/73022841007/
Madrigal Pharma surges after drug wins first approval for fatty liver disease NASH
reuters.com/business/healthcare-pharmaceuticals/madrigal-pharma-surges-fda-nod-first-drug-fatty-liver-disease-nash-2024-03-15/
No End in Sight for National ADHD Drug Shortage: Nearly 18 months after the FDA first acknowledged a national shortage of Adderall, there is now a widespread ...
webmd.com/add-adhd/news/20240312/cm/national-adhd-drug-shortage-continues
Overseas Shipholding Group, Inc. 2023 Q4 - Results - Earnings Call Presentation: The following slide deck was published by Overseas Shipholding Group, Inc.
seekingalpha.com/article/4677353-overseas-shipholding-group-inc-2023-q4-results-earnings-call-presentation
Paid articlePaid
Juicy 5% Yields Are Now Rare — But They're Still Out There: Don't kick yourself if you didn't load up on investments returning 5% on your cash ...
investors.com/etfs-and-funds/sectors/sp500-juicy-yields-are-now-rare-but-theyre-still-out-there/
Merck & Co., Inc. (MRK) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
seekingalpha.com/article/4677724-merck-and-co-inc-mrk-presents-barclays-26th-annual-global-healthcare-conference-transcript
FDA Issues New Guidance for Early Alzheimer's Drug Development: The FDA embraces the use of biomarkers and surrogate endpoints in its most recent guidance on ...
medscape.com/viewarticle/fda-issues-new-guidance-early-alzheimers-drug-development-2024a100052v
Paid articlePaid
NN, Inc. (NNBR) Q4 2023 Earnings Call Transcript: NN, Inc. (NASDAQ:NASDAQ:NNBR) Q4 2023 Results Conference Call March 12, 2024 9:00 AM ETCompany ...
seekingalpha.com/article/4677671-nn-inc-nnbr-q4-2023-earnings-call-transcript
FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’
cnn.com/2024/03/26/health/winrevair-pah-drug-approval/
Paid articlePaid
Reproductive rights before Supreme Court again with abortion pill access at stake
pbs.org/newshour/show/reproductive-rights-before-supreme-court-again-with-abortion-pill-access-at-stake
NVIDIA Corporation (NVDA) GTC Financial Analyst Q&A - (Transcript): NVIDIA Corporation (NASDAQ:NASDAQ:NVDA) GTC Financial Analyst Q&A Call March 19 ...
seekingalpha.com/article/4679228-nvidia-corporation-nvda-gtc-financial-analyst-q-transcript
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics